Logo image of KEQU

KEWAUNEE SCIENTIFIC CP (KEQU) Stock Fundamental Analysis

NASDAQ:KEQU - Nasdaq - US4928541048 - Common Stock - Currency: USD

36.9  -0.41 (-1.1%)

Fundamental Rating

4

Taking everything into account, KEQU scores 4 out of 10 in our fundamental rating. KEQU was compared to 189 industry peers in the Health Care Equipment & Supplies industry. KEQU has only an average score on both its financial health and profitability. KEQU has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

In the past year KEQU was profitable.
In the past year KEQU had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: KEQU reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: KEQU reported negative operating cash flow in multiple years.
KEQU Yearly Net Income VS EBIT VS OCF VS FCFKEQU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M

1.2 Ratios

KEQU has a better Return On Assets (9.29%) than 91.53% of its industry peers.
KEQU has a better Return On Equity (28.92%) than 98.41% of its industry peers.
The Return On Invested Capital of KEQU (8.35%) is better than 88.89% of its industry peers.
Industry RankSector Rank
ROA 9.29%
ROE 28.92%
ROIC 8.35%
ROA(3y)3.12%
ROA(5y)-0.07%
ROE(3y)6.34%
ROE(5y)-0.44%
ROIC(3y)N/A
ROIC(5y)N/A
KEQU Yearly ROA, ROE, ROICKEQU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

1.3 Margins

KEQU has a Profit Margin of 7.99%. This is amongst the best in the industry. KEQU outperforms 81.48% of its industry peers.
In the last couple of years the Profit Margin of KEQU has grown nicely.
KEQU's Operating Margin of 6.73% is fine compared to the rest of the industry. KEQU outperforms 74.60% of its industry peers.
KEQU's Operating Margin has improved in the last couple of years.
KEQU's Gross Margin of 27.02% is on the low side compared to the rest of the industry. KEQU is outperformed by 77.25% of its industry peers.
In the last couple of years the Gross Margin of KEQU has grown nicely.
Industry RankSector Rank
OM 6.73%
PM (TTM) 7.99%
GM 27.02%
OM growth 3YN/A
OM growth 5Y44.33%
PM growth 3YN/A
PM growth 5Y55.17%
GM growth 3Y16.23%
GM growth 5Y8.16%
KEQU Yearly Profit, Operating, Gross MarginsKEQU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20 25

More info and screens

4

2. Health

2.1 Basic Checks

KEQU has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for KEQU has been increased compared to 1 year ago.
Compared to 5 years ago, KEQU has more shares outstanding
KEQU has a better debt/assets ratio than last year.
KEQU Yearly Shares OutstandingKEQU Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M
KEQU Yearly Total Debt VS Total AssetsKEQU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

KEQU has an Altman-Z score of 2.69. This is not the best score and indicates that KEQU is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.69, KEQU is in the better half of the industry, outperforming 68.25% of the companies in the same industry.
The Debt to FCF ratio of KEQU is 17.20, which is on the high side as it means it would take KEQU, 17.20 years of fcf income to pay off all of its debts.
KEQU has a better Debt to FCF ratio (17.20) than 71.43% of its industry peers.
KEQU has a Debt/Equity ratio of 1.04. This is a high value indicating a heavy dependency on external financing.
KEQU has a Debt to Equity ratio of 1.04. This is in the lower half of the industry: KEQU underperforms 75.66% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.04
Debt/FCF 17.2
Altman-Z 2.69
ROIC/WACC1.05
WACC7.99%
KEQU Yearly LT Debt VS Equity VS FCFKEQU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

2.3 Liquidity

A Current Ratio of 2.16 indicates that KEQU has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.16, KEQU is doing worse than 62.96% of the companies in the same industry.
A Quick Ratio of 1.54 indicates that KEQU should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.54, KEQU is doing worse than 60.32% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.16
Quick Ratio 1.54
KEQU Yearly Current Assets VS Current LiabilitesKEQU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 99.63% over the past year.
Measured over the past years, KEQU shows a very strong growth in Earnings Per Share. The EPS has been growing by 64.49% on average per year.
KEQU shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.44%.
Measured over the past years, KEQU shows a small growth in Revenue. The Revenue has been growing by 6.81% on average per year.
EPS 1Y (TTM)99.63%
EPS 3YN/A
EPS 5Y64.49%
EPS Q2Q%28.24%
Revenue 1Y (TTM)9.44%
Revenue growth 3Y11.37%
Revenue growth 5Y6.81%
Sales Q2Q%43.59%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
KEQU Yearly Revenue VS EstimatesKEQU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
KEQU Yearly EPS VS EstimatesKEQU Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 0.5 1 1.5

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 6.24, the valuation of KEQU can be described as very cheap.
KEQU's Price/Earnings ratio is rather cheap when compared to the industry. KEQU is cheaper than 97.88% of the companies in the same industry.
KEQU's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.70.
Industry RankSector Rank
PE 6.24
Fwd PE N/A
KEQU Price Earnings VS Forward Price EarningsKEQU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

93.65% of the companies in the same industry are more expensive than KEQU, based on the Enterprise Value to EBITDA ratio.
83.07% of the companies in the same industry are more expensive than KEQU, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 27.02
EV/EBITDA 8.64
KEQU Per share dataKEQU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The decent profitability rating of KEQU may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.1
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

KEQU does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

KEWAUNEE SCIENTIFIC CP

NASDAQ:KEQU (5/19/2025, 8:00:02 PM)

36.9

-0.41 (-1.1%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-12 2025-03-12/amc
Earnings (Next)06-24 2025-06-24
Inst Owners44.09%
Inst Owner Change-4.72%
Ins Owners16.11%
Ins Owner Change-3.25%
Market Cap105.17M
Analysts82.86
Price TargetN/A
Short Float %2.14%
Short Ratio1.89
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 6.24
Fwd PE N/A
P/S 0.48
P/FCF 27.02
P/OCF 16.13
P/B 1.73
P/tB 3.7
EV/EBITDA 8.64
EPS(TTM)5.91
EY16.02%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.37
FCFY3.7%
OCF(TTM)2.29
OCFY6.2%
SpS77.2
BVpS21.33
TBVpS9.98
PEG (NY)N/A
PEG (5Y)0.1
Profitability
Industry RankSector Rank
ROA 9.29%
ROE 28.92%
ROCE 10.66%
ROIC 8.35%
ROICexc 8.96%
ROICexgc 11.91%
OM 6.73%
PM (TTM) 7.99%
GM 27.02%
FCFM 1.77%
ROA(3y)3.12%
ROA(5y)-0.07%
ROE(3y)6.34%
ROE(5y)-0.44%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y44.49%
ROICexc growth 3YN/A
ROICexc growth 5Y44.49%
OM growth 3YN/A
OM growth 5Y44.33%
PM growth 3YN/A
PM growth 5Y55.17%
GM growth 3Y16.23%
GM growth 5Y8.16%
F-Score5
Asset Turnover1.16
Health
Industry RankSector Rank
Debt/Equity 1.04
Debt/FCF 17.2
Debt/EBITDA 3.35
Cap/Depr 65.66%
Cap/Sales 1.19%
Interest Coverage 250
Cash Conversion 34.65%
Profit Quality 22.14%
Current Ratio 2.16
Quick Ratio 1.54
Altman-Z 2.69
F-Score5
WACC7.99%
ROIC/WACC1.05
Cap/Depr(3y)117.83%
Cap/Depr(5y)107.18%
Cap/Sales(3y)1.72%
Cap/Sales(5y)1.69%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)99.63%
EPS 3YN/A
EPS 5Y64.49%
EPS Q2Q%28.24%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)9.44%
Revenue growth 3Y11.37%
Revenue growth 5Y6.81%
Sales Q2Q%43.59%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-3.94%
EBIT growth 3YN/A
EBIT growth 5Y54.15%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y130.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y163.01%
OCF growth 3Y178.06%
OCF growth 5Y51.03%